Skip to main content

Table 2 Number of statins on KNHI benefit list (2005–2009 year)*

From: Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea

Year 2005 2006 2007 2008 2009
Statins Original Generic** Original Generic** Original Generic** Original Generic** Original Generic**
Simvastatin (10, 20, 40, 80 mg) 3 125 3 134 3 135 3 118 4 100
Lovastatin (20 mg) 1 54 1 56 1 52 1 35 1 25
Pravastatin (5,10,20,40 mg) 0 49 0 50 0 81 0 56 0 48
Fluvastatin (20,40,80 mg) 3 0 3 0 3 0 3 0 3 0
Atorvastatin (10,20,40,80 mg) 3 0 3 0 3 0 4 42 4 54
Rosuvastatin (5,10,20 mg) 2 0 3 0 3 0 3 0 3 0
Pitavastatin (2 mg) 1 0 1 0 1 0 1 0 1 0
Total 241 254 282 266 243
  1. *They include all statins on the KNHI benefit list between 2005 and 2009, regardless of whether they were actually prescribed or not.
  2. **The original and generic drugs were categorized only according to their ingredients and contents. Different administration routes, dosage forms, and strength of unit were not taken into account.